Literature DB >> 18563715

HIF-1 alpha: a key survival factor for serum-deprived prostate cancer cells.

Rusha Thomas1, Myoung H Kim.   

Abstract

BACKGROUND: Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF-1 alpha expression, and the function of HIF-1 alpha in regulating the survival of normoxic serum-deprived PCa cells.
METHODS: HIF-1 alpha protein was assessed by immunoblots. Cell viability and proliferation were assessed by trypan blue assay and flow cytometric analysis. Transcriptional activity was assessed by luciferase reporter assay and RT-PCR. HIF-1 alpha expression was suppressed with siRNA. Activities of HIF-1 alpha-target genes were inhibited with neutralizing antibody.
RESULTS: Prolonged serum deprivation is a potent inducer of HIF-1 alpha in PC-3 and LNCaP PCa cells, despite normal oxygen conditions. In contrast, cells grown in the presence of serum did not show HIF-1 alpha protein accumulation. Moreover, HIF-1 alpha protein increase during serum deprivation correlated with increased cell survival, while suppression of HIF-1 alpha expression significantly decreased PCa cell viability. Our results further demonstrate that HIF-1 alpha protein increase is due to increased HIF-1 alpha protein synthesis. First, there was no significant increase in HIF-1 alpha mRNA. Secondly, cycloheximide, a protein synthesis inhibitor, prevented HIF-1 alpha protein increase in serum-deprived PCa cells. Moreover, the expression of HIF-1 alpha-target genes, VEGF and IGF-2, was concomitantly increased in serum-deprived PCa cells, while suppression of HIF-1 alpha expression significantly inhibited their induction. Furthermore, inhibition of IGF-2 activity resulted in a significant decline in PCa cell survival.
CONCLUSION: PCa cells counteract the stress of prolonged serum deprivation by upregulating HIF-1 alpha protein which increases IGF-2 expression to promote cell survival. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563715      PMCID: PMC2593855          DOI: 10.1002/pros.20808

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  38 in total

Review 1.  Growth factor signaling in cell survival: implications for cancer treatment.

Authors:  S Talapatra; C B Thompson
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

2.  Transcription. Oxygen sensing gets a second wind.

Authors:  Richard K Bruick; Steven L McKnight
Journal:  Science       Date:  2002-02-01       Impact factor: 47.728

3.  Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.

Authors:  Y E Whang; X Wu; H Suzuki; R E Reiter; C Tran; R L Vessella; J W Said; W B Isaacs; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate.

Authors:  J A Doll; F K Reiher; S E Crawford; M R Pins; S C Campbell; N P Bouck
Journal:  Prostate       Date:  2001-12-01       Impact factor: 4.104

5.  A conserved family of prolyl-4-hydroxylases that modify HIF.

Authors:  R K Bruick; S L McKnight
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

6.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

7.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

8.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

9.  Loss of PTEN facilitates HIF-1-mediated gene expression.

Authors:  W Zundel; C Schindler; D Haas-Kogan; A Koong; F Kaper; E Chen; A R Gottschalk; H E Ryan; R S Johnson; A B Jefferson; D Stokoe; A J Giaccia
Journal:  Genes Dev       Date:  2000-02-15       Impact factor: 11.361

10.  Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis.

Authors:  N de Paulsen; A Brychzy; M C Fournier; R D Klausner; J R Gnarra; A Pause; S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  11 in total

1.  Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer.

Authors:  Howard S Kim; Elizabeth M Masko; Susan L Poulton; Kelly M Kennedy; Salvatore V Pizzo; Mark W Dewhirst; Stephen J Freedland
Journal:  BJU Int       Date:  2012-03-06       Impact factor: 5.588

2.  Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha.

Authors:  Alessio Paone; Roberta Galli; Chiara Gabellini; Dmitriy Lukashev; Donatella Starace; Agnes Gorlach; Paola De Cesaris; Elio Ziparo; Donatella Del Bufalo; Michail V Sitkovsky; Antonio Filippini; Anna Riccioli
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

3.  Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma.

Authors:  Xiang Yuan; Jiangtu He; Fenyong Sun; Jiang Gu
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

4.  Aloe-emodin suppresses hypoxia-induced retinal angiogenesis via inhibition of HIF-1α/VEGF pathway.

Authors:  Jianming Wu; Xiao Ke; Wei Wang; Hongcheng Zhang; Na Ma; Wei Fu; Manxi Zhao; Xiaoping Gao; Xiaofeng Hao; Zhirong Zhang
Journal:  Int J Biol Sci       Date:  2016-10-25       Impact factor: 6.580

5.  Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia.

Authors:  Clara Pérez-Rambla; Leonor Puchades-Carrasco; María García-Flores; José Rubio-Briones; José Antonio López-Guerrero; Antonio Pineda-Lucena
Journal:  Metabolomics       Date:  2017-03-09       Impact factor: 4.290

6.  Formononetin, an active compound of Astragalus membranaceus (Fisch) Bunge, inhibits hypoxia-induced retinal neovascularization via the HIF-1α/VEGF signaling pathway.

Authors:  Jianming Wu; Xiao Ke; Na Ma; Wei Wang; Wei Fu; Hongcheng Zhang; Manxi Zhao; Xiaoping Gao; Xiaofeng Hao; Zhirong Zhang
Journal:  Drug Des Devel Ther       Date:  2016-09-23       Impact factor: 4.162

7.  Silencing prion protein in MDA-MB-435 breast cancer cells leads to pleiotropic cellular responses to cytotoxic stimuli.

Authors:  Guohua Yu; Liming Jiang; Yuanyuan Xu; Hongwei Guo; Huiyan Liu; Yi Zhang; Huaiyi Yang; Chonggang Yuan; Jiyan Ma
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

8.  Hypoxia-inducible factor prolyl hydroxylase inhibitor prevents steroid-associated osteonecrosis of the femoral head in rabbits by promoting angiogenesis and inhibiting apoptosis.

Authors:  Lihong Fan; Jia Li; Zefeng Yu; Xiaoqian Dang; Kunzheng Wang
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

9.  Ferroquine, the next generation antimalarial drug, has antitumor activity.

Authors:  Artem Kondratskyi; Kateryna Kondratska; Fabien Vanden Abeele; Dmitri Gordienko; Charlotte Dubois; Robert-Allain Toillon; Christian Slomianny; Sébastien Lemière; Philippe Delcourt; Etienne Dewailly; Roman Skryma; Christophe Biot; Natalia Prevarskaya
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

10.  Enhanced anti-angiogenic activity of novel melatonin-like agents.

Authors:  Su Jung Hwang; Yeonghun Jung; Ye-Seul Song; Suryeon Park; Yohan Park; Hyo-Jong Lee
Journal:  J Pineal Res       Date:  2021-05-13       Impact factor: 13.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.